Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics, Inc. (LXEO) Operating Expenses (2022 - 2023)

Lexeo Therapeutics' Operating Expenses history spans 2 years, with the latest figure at $15.0 million for Q4 2023.

  • For Q4 2023, Operating Expenses rose 31.5% year-over-year to $15.0 million; the TTM value through Dec 2023 reached $68.5 million, changed N/A, while the annual FY2024 figure was $105.8 million, 54.37% up from the prior year.
  • Operating Expenses for Q4 2023 was $15.0 million at Lexeo Therapeutics, down from $20.3 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $20.3 million in Q3 2023 and bottomed at $11.4 million in Q4 2022.